Investigating how a specific protein helps deliver zinc to cells during infections

The role of the ZNG1 metallochaperone in the host response to infection

NIH-funded research Vanderbilt University Medical Center · NIH-10881931

This study is looking at a protein called ZNG1 that helps move zinc into other proteins important for fighting infections, and it's for anyone interested in how zinc deficiency can affect our immune system and overall health.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionVanderbilt University Medical Center NIH-funded
Lab location1 site (Nashville, United States)
Project IDNIH-10881931 on NIH RePORTER

What this research studies

This research focuses on understanding the role of a protein called ZNG1, which is crucial for transporting zinc into other proteins that help the body respond to infections. Zinc is essential for many cellular functions, and its deficiency can lead to serious health issues, including immune dysfunction and increased susceptibility to infections. The study aims to uncover the molecular mechanisms behind how ZNG1 operates, using various biochemical and physiological experiments to explore its interactions with other proteins. By understanding these processes, the research hopes to shed light on the broader implications of zinc deficiency in human health.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals suffering from zinc deficiency, which may include those with malnutrition or certain chronic health conditions.

Not a fit: Patients who have adequate zinc levels or those with conditions unrelated to zinc metabolism may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new strategies for improving immune function and reducing infection risk in individuals with zinc deficiency.

How similar studies have performed: Previous research has shown promising results in understanding the role of metallochaperones in cellular processes, suggesting that this approach could yield valuable insights.

Where this research is happening

Nashville, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Cancers
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.